Evidence map›Paper›PMID 42418135›Full record

ArticleJournal of thrombosis and thrombolysis2026

Ginsenoside Rg1 attenuates platelet activation under shear stress via multi-target suppression of PI3K/AKT and ERK1/2 pathways: an in vitro microfluidic study.

Zhi-Yin Ke, Xiao-Jing Huang, Dan-Ning Liu, Xue-Mei Gao, Bei-Zhong Liu, Yuan Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhi-Yin KeCentral Laboratory, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China.
Xiao-Jing HuangCentral Laboratory, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China.
Dan-Ning LiuDepartment of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Xue-Mei GaoCentral Laboratory, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China. 13228374289@163.com.
Bei-Zhong LiuCentral Laboratory, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China. liubeizhong@cqmu.edu.cn.
Yuan LiCentral Laboratory, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China. liyuan@cqmu.edu.cn.ORCID https://orcid.org/0000-0002-1202-796X

Funding

General Project of the Chongqing Science and Technology Bureau cstc2021jcyj-msxmX0211Joint project of Chongqing Health Commission and Science and Technology Bureau 2023GDRC008National Natural Science Foundation of China 11702047Scientific Research Project of Yongchuan Hospital Affiliated to Chongqing Medical University YJJL2024034
6 · The paper itself

Abstract

Ginsenoside Rg1, a key bioactive component of Panax ginseng, is recognized for its cardiovascular protective effects, yet its role in modulating platelet activation under high shear stress remains incompletely understood. This study aimed to systematically evaluate the in vitro effects and underlying mechanisms of Rg1 on platelet aggregation under high shear stress using a microfluidic chip system. In this study, blood flow environments at venous (300 s

Indexed as

Arterial thrombosisGinsenoside Rg1Microfluidic chipPlatelet aggregationShear stress

Identifiers

PMID42418135

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.